Effective Analytic and Remotely Monitoring Smart Drug Delivery System based on IoMT with KNN classifier of Epilepsy Patients
Main Article Content
Abstract
Chronic, non-communicable brain disorder, epilepsy is one of the most severe neurologic disorders. Worldwide, about 50 million individuals (2.5 percent) have Epilepsy, rendering it one of the world's most severe neurological disorders. [1]. About 80% of individuals with epilepsy work in countries with small to modest income. A medically refractory solution for the seizure control for a large fraction of affected patients. Here we explain the IMoT structure for a single drug delivery network. This has resulted in injection of drugs when seizure seizures have been identified. A powerful micro-pump electromagnetically powered with a polydimethylsiloxane (PDMS) diaphragm was used to distribute the drug. Simulink ® and ThingspeakTM were the prototype for the solution. The findings of the simulation reveal that the device proposed preserves high precision performance while substantially reducing power usage (8-26 %)..
Downloads
Metrics
Article Details
Licensing
TURCOMAT publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
